Roche/Memory Alzheimer’s Trial Will Proceed Following Lift Of Clinical Hold
This article was originally published in The Pink Sheet Daily
Executive Summary
Memory will launch a Phase IIa trial of MEM 3454 in first quarter 2007 after it resolved FDA questions about toxicology reports.